|
Question
|
4
|
Resverlogix Corp.
|
Feb 23, 2021 01:37PM
|
|
Re: Finance
|
1
|
Resverlogix Corp.
|
Feb 23, 2021 04:50PM
|
|
Re: Question
|
6
|
Resverlogix Corp.
|
Feb 24, 2021 06:43PM
|
|
Re: Question
|
6
|
Resverlogix Corp.
|
Feb 25, 2021 01:09PM
|
|
Re: Question
|
1
|
Resverlogix Corp.
|
Feb 25, 2021 01:18PM
|
|
Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model
|
8
|
Resverlogix Corp.
|
Mar 03, 2021 10:31AM
|
|
Re: Alberta
|
5
|
Resverlogix Corp.
|
Mar 03, 2021 11:10AM
|
|
Re: Australia Associated Press
|
6
|
Resverlogix Corp.
|
Mar 03, 2021 06:17PM
|
|
Zenith University
|
5
|
Zenith Epigenetics
|
Mar 05, 2021 11:57AM
|
|
Re: Yes , it seems like a hundred years ago...
|
8
|
Resverlogix Corp.
|
Mar 08, 2021 10:55AM
|
|
Re: Don't See Us Listed but thought it might interest some
|
6
|
Resverlogix Corp.
|
Mar 10, 2021 11:57AM
|
|
Re: Pharmacological Modulation of BET Family in Sepsis
|
3
|
Resverlogix Corp.
|
Mar 11, 2021 11:36AM
|
|
Re: Local TV Station Global Calgary
|
7
|
Resverlogix Corp.
|
Mar 12, 2021 10:53AM
|
|
Re: Local TV Station Global Calgary
|
2
|
Resverlogix Corp.
|
Mar 12, 2021 05:10PM
|
|
Re: RVX's place in therapy - future prediction
|
2
|
Resverlogix Corp.
|
Mar 13, 2021 04:31PM
|
|
Re: Apabetalone Inhibits SARS-CoV-2 Infection at Levels Comparable to Approved Antiviral
|
4
|
Resverlogix Corp.
|
Mar 15, 2021 11:02AM
|
|
Re: Zenith-Oncology Pipeline
|
4
|
Zenith Epigenetics
|
Mar 19, 2021 11:19AM
|
|
Re: We should get financials this week
|
3
|
Resverlogix Corp.
|
Mar 22, 2021 12:07PM
|
|
Re: New pill from Pfizer....
|
8
|
Resverlogix Corp.
|
Mar 24, 2021 11:02AM
|
|
Re: Why have we not heard more about CURATE-AI?
|
2
|
Zenith Epigenetics
|
Mar 25, 2021 11:12AM
|
